首页 >
法规速递
-
Page: Submitting results of paediatric studies-2026/3/27
2026-03-30查看详情 > -
Page: Periodic safety update reports (PSURs)-2026/3/27
2026-03-30查看详情 > -
Page: Data quality framework for medicines regulation-2026/3/27
2026-03-30查看详情 > -
Page: Risk management plans (RMP) in post-authorisation phase: questions and answers-2026/3/27
2026-03-30查看详情 > -
Document: Data Quality Framework for EU medicines regulation: application to Real-World Data-2026/3/27
2026-03-30查看详情 > -
Document: Outcome of the public consultation on the Data Quality Framework for EU Medicines Regulation: application to Real-World Data-2026/3/27
2026-03-30查看详情 > -
Page: Post-authorisation measures: questions and answers-2026/3/27
2026-03-30查看详情 > -
Page: Post-authorisation safety studies (PASS)-2026/3/27
2026-03-30查看详情 > -
Page: Type-IB variations: questions and answers-2026/3/27
2026-03-30查看详情 > -
Page: Worksharing: questions and answers-2026/3/27
2026-03-30查看详情 >
